Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating heart failure and fibrotic disorders using modified relaxin polypeptides

Methods of treating heart failure and fibrotic disorders using modified relaxin polypeptides

US Patent 11311605 · Granted Apr 26, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of c-type natriuretic peptide variants to treat osteoarthritis2025
Anti-CD70 antibody drug conjugates2024
Anti-CD70 antibody drug conjugates2024
Modified FGF-21 polypeptides with non-naturally encoded amino acids2024
Modified FGF-21 polypeptides with non-naturally encoded amino acids2024
Modified FGF-21 polypeptides with non-naturally encoded amino acids2024
Modified relaxin polypeptides and their uses2023
Modified relaxin polypeptides and their uses2023
Modified relaxin polypeptides and their uses2023
Modified relaxin polypeptides and their uses2023
Modified relaxin polypeptides and their uses2023
Modified relaxin polypeptides and their uses2023